SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Striyker who wrote (2019)6/28/1998 9:06:00 PM
From: jmt  Read Replies (1) | Respond to of 5402
 
Many of these statements make sense:

Third: Wonder where the money is coming from to pay Battelle?

- I they believe in the technology, financing could be similar to Venture Capital, ie. % of ownership.

Fourth: Would think that SGNC's best bet is for a buyout.

Not necessarily. Once approved, many Biotechs provide a license to an established Pharm to market the product. If a minimal amount of cash is needed for manufacturing, why give up or share the potential revenue.

Fifth: Don't call Baxter or J&J. Biotech is a small world. Many of the scientists working on a blood substitute already know each other. Some may have worked together.

Absolutely. They make so many of these small investments, IR would not even be in the loop.

jmt



To: Striyker who wrote (2019)6/28/1998 9:58:00 PM
From: Jim B  Respond to of 5402
 
thankyou whomever you are.. however, remaing unknown takes away
from the credibility of this persons posts of course.. but nice to
know that there are people out there looking into this one..

I think this post just reconfirms our beliefs that SGNC IS being
looked at by many different people/institutions..

I would think that BATELLE is probably getting its money already
from Baxter or one of the others but that currently they are being
quiet about it.. just speculation on my part..

As for this persons #4 that SGNC's best bet is a buyout... ABSOLUTELY.. and imho if things remain as they are... it will come
pretty soon.. maybe a few months to half a year.. maybe sooner.. hard
to tell.. can someone comment on the "primate testing"?
jim